KMT2A and acute leukemia: Several studies demonstrated that 11q23 is susceptible to double strand breaks resulting from inhibition of topoisomerase II [6]; this specific susceptibility can explain the high incidence of MLL aberrations occurring in secondary acute leukemias (i.e., therapy-related acute myeloid leukemia, especially after treatment with topoisomerase II inhibitors).